ROCKWELL MEDICAL, INC. (RMTI) Guidance & Earnings Results
On 2026-08-13 ROCKWELL MEDICAL, INC. reaffirmed guidance: "Net Sales $70M-$75M, Gross Margin 18%-22%, Adjusted EBITDA $1M-$2M, Operating Cash Flow…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RMTIROCKWELL MEDICAL, INC.Follow RMTI — free
—
Price chart with a free account
- Market cap
- 28.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 13 Aug 26 | Reaffirmed | Net Sales $70M-$75M, Gross Margin 18%-22%, Adjusted EBITDA $1M-$2M, Operating Cash Flow Positive · full year |
| 7 May 26 | Reaffirmed | FY2026 net sales $70.0M to $75.0M; gross margin 18% to 22%; Adjusted EBITDA $1.0M to $2.0M; operating cash flow positive · full year |
| 12 Nov 25 | Reaffirmed | FY2025 net sales $65.0M to $70.0M; gross margin 16% to 18%; Adjusted EBITDA ($0.5M) · full year |
| 14 Aug 25 | Reaffirmed | FY2025 net sales $65.0M to $70.0M; gross margin 16% to 18%; Adjusted EBITDA ($0.5)M to $0.5M · full year |
ROCKWELL MEDICAL, INC. — questions
- What guidance did ROCKWELL MEDICAL, INC. give?
- On 2026-08-13: "Net Sales $70M-$75M, Gross Margin 18%-22%, Adjusted EBITDA $1M-$2M, Operating Cash Flow Positive"
- When does ROCKWELL MEDICAL, INC. report earnings?
- ROCKWELL MEDICAL, INC.'s next earnings report is expected on 2026-11-12.
Every figure on this page comes from ROCKWELL MEDICAL, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.